Literature DB >> 33426586

Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients.

Harish Goyal1, Anshul Sharma1, Chetan Patel2,3, K K Deepak4, Madhavi Tripathi1, Priyanka Gupta1, Rajeev Kumar1, Chandra Shekhar Bal1, Vinay Goyal5.   

Abstract

BACKGROUND: Dysfunction and denervation of myocardial nor-adrenergic sympathetic neurons has been documented in IPD patients with dysautonomia. The aim of this study was to evaluate the feasibility of single tracer imaging of myocardial sympathetic and cerebral striatal involvement in these patients.
METHODS: Twenty-two controls (mean-age 59.09 ± 12.39 years, 15 men) with no clinical autonomic-dysfunction and normal striatal-uptake in 18F-FDOPA-PET/CT; and 28 patients (mean-age 58.18 ± 8.25 years, 18 men) with autonomic-dysfunction (in Autonomic Function Tests) and striatal dopaminergic-dysfunction were enrolled. Both cardiac-PET/CT (40 minutes post IV-injection of 185-259MBq 18F-FDOPA) and Brain-PET/CT (60 minutes post-IV) were acquired in same session. ROIs were drawn over the entire left ventricular myocardium, individual walls and mediastinum for quantification. Patients and controls were followed-up for 26.93 ± 5.43 months and 37.91 ± 8.63 months, respectively.
RESULTS: Striatal and myocardial-parameters were significantly lower in patients compared to controls; with Myocardium/mediastinal ratio (MwMR) yielding the area-under-the-curve of .941 (P < .001). MwMR correlated negatively with the drop in systolic blood pressure (SBP) during AFTs {Pearson-coefficient (-).565, P = .002}. Mean MwMR in patients with abnormal-AFTs was significantly lower than patients with borderline-AFTs (1.39 ± .12 vs 1.55 ± .10; P = .002). 9/20 patients with abnormal-AFTs showed functional worsening during follow-up, compared to 2/8 with borderline-AFTs.
CONCLUSION: Single tracer, single session imaging of striatal and cardiac sympathetic dysfunction in patients with advanced IPD is feasible with use of 18F-FDOPA. Significantly reduced 18F-FDOPA uptake is seen in the myocardium of the IPD patients with sympathetic dysfunction.
© 2021. American Society of Nuclear Cardiology.

Entities:  

Keywords:  18F-FDOPA; IPD; PET/CT; autonomic function tests; cardiac sympathetic denervation

Mesh:

Substances:

Year:  2021        PMID: 33426586     DOI: 10.1007/s12350-020-02474-w

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  21 in total

1.  Sympathetic cardioneuropathy in dysautonomias.

Authors:  D S Goldstein; C Holmes; R O Cannon; G Eisenhofer; I J Kopin
Journal:  N Engl J Med       Date:  1997-03-06       Impact factor: 91.245

Review 2.  The clinical symptoms of Parkinson's disease.

Authors:  Sigurlaug Sveinbjornsdottir
Journal:  J Neurochem       Date:  2016-07-11       Impact factor: 5.372

Review 3.  Diagnosis and management of diabetic autonomic neuropathy.

Authors:  D J Ewing; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-02

Review 4.  The genetic epidemiology of neurodegenerative disease.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

5.  Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases.

Authors:  David S Goldstein; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

6.  Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.

Authors:  G Eisenhofer; D Hovevey-Sion; I J Kopin; R Miletich; K L Kirk; R Finn; D S Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

7.  Spectrum of abnormalities of sympathetic tyrosine hydroxylase and alpha-synuclein in chronic autonomic failure.

Authors:  Risa Isonaka; Patti Sullivan; Yunden Jinsmaa; Abraham Corrales; David S Goldstein
Journal:  Clin Auton Res       Date:  2018-02-02       Impact factor: 4.435

8.  A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.

Authors:  P Cumming; H Kuwabara; A Gjedde
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

9.  6-Fluorocatecholamines as false adrenergic neurotransmitters.

Authors:  C C Chiueh; Z Zukowska-Grojec; K L Kirk; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1983-06       Impact factor: 4.030

Review 10.  'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?

Authors:  Sean J Udow; Andrew D Robertson; Bradley J MacIntosh; Alberto J Espay; James B Rowe; Anthony E Lang; Mario Masellis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-09-09       Impact factor: 10.154

View more
  2 in total

1.  [18F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?

Authors:  Giorgio Treglia; Arnoldo Piccardo; Valentina Garibotto
Journal:  Clin Auton Res       Date:  2022-09-09       Impact factor: 5.625

Review 2.  PET Tracers for Imaging Cardiac Function in Cardio-oncology.

Authors:  James M Kelly; John W Babich
Journal:  Curr Cardiol Rep       Date:  2022-01-13       Impact factor: 2.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.